Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
The wait for results is becoming more and more painful. Lets hope the reward is worth it!
Yeah apparently the talk tomorrow with RM is actually a talk from last month.
Theyve got to be waiting for the day 90 data otherwsie surely we would have something by now.
Yeah really hoping we get something tomorrow. I know we supposed to be patient...etc but we haven't had an RNS in ages and then we get one which wasn't exactly good news.
Doc, I get what youre saying. in terms of EUA and getting ahead of the race then long covid data may not needed. Which i guess is true.
However, I think SNG need data, data and more data . As many posters on here will agree, SNG have been overlooked over and over again. I think RM wants to use as much data as possible to give him the ammunition so cant be ignored by anyone again. Lets hope its enough!
Regarding long covid symptoms... not much is understood about post viral syndromes and why they occur. You get patients with similar long symptoms in cases Post flu and glandular fever and can often be irrespective of how bad the initial infection actually was. Its all quite bizarre.
I think they are going to wait until 90 day long covid data because if it indeed does work it will give the drug a bit of a wow factor and grab more attention. I really do hope the wait is not much longer now.
Yeah the more I think about it I think the results will come a bit later on in April. Was hoping it would be next week!
Prosecco - I agree they will negotiate hard. This is also why I think Home trial results (if good) will be quite pivotal in Synairgens journey and maybe be the true catalyst they need. P3 and Active2 obviously great but if they can prove they can prevent hospital admissions it should generate a lot of attention.
Americas use of it would be interesting. I think (if approved) they will use it much more freely given its not tax payers money.
For example if it is proven to prevent long covid - Theyd more likely use it for this indication too meaning they may just give it to almost anyone who is symptomatic with covid and not just at risk groups.
I feel helpless talking to long covid patients just nothing i can do for them.
I was actually giving this a think the other day. I cant give a precise answer (now i feel like a policitician). I think it will depend on the home study and how efficacious it is in preventing admissions. - This is key.
They say an average bed day in NHS costs around £200 but in reality i think its closer to £400 and an ITU bed can go up to £2000/day. The average over 65 admitted with pneumonia costs about £5000 per admission in total.
However I am not aware of how much the average cost is for covid pneuominitis specifically.
So if it does prove to be efficacious in preventing admissions, i imagine it will be prioritised for the at risk groups and be given in the community/ home as the cost benefit analysis should show that NHS should save money ( maybe even at cost of 2000 per treatment). ( i know i have assumed everyone at risk with covid will be admitted - which is of course not true)
I also imagine everyone admitted would get the treatment providing there are no contrindications.
Im sure theres a lot more to it but I would these are the kind of questions NICE/ commisioning groups will be asking.
Yes we have been experiencing somethin similar with surgery I work at (im a gp) I think alot of it is to do with the coding of patients and so they can accidently be given a different priority.